Showing results (271-280 of 346) with videos related to
Sort By:
Pageof 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPPM R Ranson, J A Radford, R Swindell, et al.British Journal of Cancer|March 1, 1977
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patientR L Powles, J Russell, T A Lister, et al.British Journal of Cancer|July 1, 1995
Phase II trial of temozolomide in low-grade non-Hodgkin's lymphomaP J Woll, D Crowther, P W Johnson, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: preliminary results of a randomized trial in progressC G Price, A Z Rohatiner, W Steward, et al.Nuclear Medicine Communications|October 1, 1988
114Inm oxine-labelled lymphocytes--therapeutic applicationsD Hamilton, R A Cowan, M Drayson, et al.Sarcoma|January 1, 1997
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue SarcomaH J Keizer, D Crowther, O S Nielsen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.Behring Institute Mitteilungen|August 1, 1988
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerM Bronchud, J H Scarffe, N Thatcher, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progressC G Price, A Z Rohatiner, W Steward, et al.Pageof 35